Sofia Alejandra Rodríguez Araña

Ms. Sofia Alejandra Rodríguez Araña

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2025 in COVID
Verified
Journal Article
Open access
PDF file
SLStephanie Lammie
Stephanie Lammie
SASofia Alejandra Rodríguez Araña
Sofia Alejandra Rodríguez Araña
CRCamilo Posada Rodriguez
Camilo Posada Rodriguez
JFJulio Flores-Cuadra
Julio Flores-Cuadra
APAmbar Pérez-Lao
Ambar Pérez-Lao
ATAdam E Tratner
Adam E Tratner
The COVID-19 pandemic exacerbated mental illness, accelerated cognitive decline, and deepened social inequalities. In low and middle-income countries (LMIC) such as Panama, it is unclear as to whether, and to what extent, the pandemic lockdowns affected cognitive, mental, and physical health of older adults. This study investigated changes in cognitive function, mental health, and physical health in a sample of Panamanian older adults assessed before and during the pandemic, and examined whether sociodemographic variables were associated with cognition and mental health. Participants completed in-person interviews between 2018 and early 2020 and a follow-up telephone interview between February and May 2021. Repeated measures analyses showed no significant changes in cognitive function or depression; however, participants reported fewer chronic illnesses. Linear regression analysis indicated that higher cognitive function during the pandemic was associated with younger age, higher education, and having sufficient income. An attrition analysis compared participants who completed both interviews to those who were lost to follow-up, revealing that participants who dropped out of the study had lower socioeconomic status and greater impairment at baseline. These findings highlight the need for targeted support for vulnerable older adults during public health crises.

26 April 2026 in Congreso Nacional de Ciencia y Tecnología – APANAC
Verified
Journal Article
Open access
PDF file
SASofia Alejandra Rodríguez Araña
Sofia Alejandra Rodríguez Araña
DODiana Oviedo
Diana Oviedo
LSLuis Santos
Luis Santos
GTGiselle Rangel Tapia
Giselle Rangel Tapia
AVAlcibiades Elias Villarreal
Alcibiades Elias Villarreal
AJAna Paula Jaén
Ana Paula Jaén
En Panamá, para 2020 las personas mayores de 60 años representaban el 12,4% de la población, y se proyecta que alcanzarán el 24% para el 2050. A pesar de este incremento demográfico, la investigación sobre los factores de riesgo asociados al envejecimiento ha sido limitada en la región. Este simposio reunió los avances del grupo Panama Aging Research Initiative – Health Disparities (PARI-HD), que aborda distintos aspectos del envejecimiento en el país. Se estudian los factores de riesgo modificables y no modificables de las demencias, particularmente la enfermedad de Alzheimer (EA), como el alelo ApoE4 como un factor de riesgo genético que incrementa la vulnerabilidad y severidad frente al SARS-CoV-2, así como frente a otras infecciones virales.El PARI-HD investiga la relación entre biomarcadores en sangre y la función cognitiva en adultos mayores panameños, con el fin de identificar predictores del deterioro cognitivo y de enfermedades neurodegenerativas como el Alzheimer. La combinación de biomarcadores en sangre, líquido cefalorraquídeo e imágenes cerebrales mejora la precisión diagnóstica, aunque su implementación plantea retos éticos y logísticos en contextos de recursos limitados.Ante la posibilidad de futuras crisis sanitarias, se enfatiza la necesidad de alternativas accesibles que consideren las dimensiones emocionales, físicas y cognitivas de las personas mayores. Dado que los tratamientos farmacológicos para la EA son aún limitados, las intervenciones no farmacológicas y las evaluaciones neuropsicológicas remotas surgen como herramientas prometedoras para preservar y mejorar la calidad de vida, adaptando la atención a las realidades locales y al progreso científico.

25 December 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SASofia Alejandra Rodríguez Araña
Sofia Alejandra Rodríguez Araña
DODiana Carolina Oviedo
Diana Carolina Oviedo
ATAdam E. Tratner
Adam E. Tratner
AVAlcibiades E Villarreal
Alcibiades E Villarreal
GRGiselle Rangel
Giselle Rangel
GBGabrielle B Britton
Gabrielle B Britton
Background: Neurodegeneration is linked to cerebrovascular diseases (CVDs) that can impair daily functioning and accelerate cognitive decline in older adults. Blood‐based biomarkers reflect neuroinflammation and cerebrovascular pathology. While many individuals with CVDs experience lasting disabilities, cognitive reserve (CR)—strengthened by lifelong experiences such as education and occupational complexity—can mitigate cognitive decline. However, access to these experiences is more limited in developing countries. The present study aims to explore the relationship between CR, blood‐based biomarkers interleukin‐18 (IL‐18), vascular cell adhesion molecule‐1 (sVCAM1), soluble intercellular adhesion molecule‐1 (sICAM1), and pancreatic polypeptide, and cognition. Method: The study includes cross sectional analyses from two samples of the Panama Aging Research Initiative‐Health Disparities study (PARI‐HD), consisting of dementia‐free, older adults aged ≥ 65 years ( N = 429). The first sample ( N = 181) was recruited during 2012‐2015 from Panama's Social Security Fund geriatric outpatient clinic (M age = 77.4 years, SD = 7.6). The second sample ( N = 248) was recruited from the community during 2016‐2020 (M age = 71.9 years, SD = 5.6). Global cognition was measured using the Mini Mental State Examination (MMSE). A composite score combining years of education, occupational complexity, and the Instrumental Activities of Daily Living (IADL) score was used to calculate CR. Results: Multivariate analyses indicated significant sex differences and differences across cohorts. Men were older, had more complex occupations, and had higher concentrations of IL18 and PPP than women. Cohort 1 was significantly older, less educated, and less independent, and had higher concentrations of biomarkers IL18, PPP, sVCAM1, sICAM1 than Cohort 2. Mediation analyses revealed that CR mediates the relationship between sVCAM1 and sICAM1 on global cognition, after controlling for age, sex, and cohort. Conclusion: These findings demonstrate an important link between neuroinflammatory biomarkers, CR, and cognition among older adults. Public policy targeting enhancing CR may decrease disability associated with neuroinflammation in developing countries like Panama.